94 related articles for article (PubMed ID: 3370069)
1. Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts.
Ogawa T; Hieda N; Sugiyama S; Toki Y; Ito T; Ogawa K; Satake T; Ozawa T
Arzneimittelforschung; 1988 Feb; 38(2):228-30. PubMed ID: 3370069
[TBL] [Abstract][Full Text] [Related]
2. The effect of cibenzoline on myocardial damages in dogs.
Taki K; Sugiyama S; Hieda N; Hanaki Y; Sano T; Shimada Y; Ozawa T
Arzneimittelforschung; 1989 Mar; 39(3):325-8. PubMed ID: 2757658
[TBL] [Abstract][Full Text] [Related]
3. Myocardial salvage by a novel thromboxane A2 synthetase inhibitor in a canine coronary occlusion-reperfusion model.
Toki Y; Hieda N; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Arzneimittelforschung; 1988 Feb; 38(2):224-7. PubMed ID: 3370068
[TBL] [Abstract][Full Text] [Related]
4. [The effect of flecainide on 2 hour occlusion-induced myocardial damages in dog].
Sugiyama S; Hieda N; Ozawa T; Fukushima A; Ogawa T; Hanaki Y
Kokyu To Junkan; 1989 Apr; 37(4):443-7. PubMed ID: 2500690
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and antiarrhythmic effects of three calcium channel antagonists in ischemic canine hearts.
Ito T; Ogawa T; Satake T; Hieda N; Sugiyama S; Ozawa T
Clin Ther; 1989; 11(4):461-71. PubMed ID: 2776164
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of bepridil on ischemic myocardial damages in dogs.
Hanaki Y; Sugiyama S; Hieda N; Taki K; Ozawa T
Arch Int Pharmacodyn Ther; 1989; 299():221-31. PubMed ID: 2789024
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thromboxane synthetase by the imidazole derivative 3-(1H-imidazol-1-yl-methyl)-2-methyl-1H-indole-1-propanoic acid as a novel therapeutic approach to experimental myocardial ischemia.
Korb H; Hoeft A; Wober W; Wolpers HG; Hellige G
Arzneimittelforschung; 1986 Jul; 36(7):1040-4. PubMed ID: 3768069
[TBL] [Abstract][Full Text] [Related]
8. The effects of SUN 1165, a novel sodium channel blocker, on ischemia-induced mitochondrial dysfunction and leakage of lysosomal enzymes in canine hearts.
Sugiyama S; Hanaki Y; Ogawa T; Hieda N; Taki K; Ozawa T
Biochem Biophys Res Commun; 1988 Dec; 157(2):433-9. PubMed ID: 2849430
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.
Kolh P; Rolin S; Tchana-Sato V; Pétein M; Ghuysen A; Lambermont B; Hanson J; Magis D; Segers P; Masereel B; D'Orio V; Dogne JM
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):53-73. PubMed ID: 16516810
[TBL] [Abstract][Full Text] [Related]
10. Interference with the prostaglandin system as a therapeutical concept to protect the myocardium during ischemic stress: experimental studies with inhibition of thromboxane synthesis.
Korb H; Hoeft A; Borowski A; de Vivie ER; Hellige G
Thorac Cardiovasc Surg; 1988 Aug; 36(4):187-93. PubMed ID: 3187978
[TBL] [Abstract][Full Text] [Related]
11. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor.
Eddy LJ; Oei HH; Glenn TM
Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567
[TBL] [Abstract][Full Text] [Related]
12. Tissue-type plasminogen activator alone or in combination with thromboxane A2 synthetase inhibitor for ischemic myocardium.
Ogawa T; Miura T; Tsuchida A; Iwamoto T; Urabe K; Endoh A; Iimura O
Can J Cardiol; 1990 Oct; 6(8):361-6. PubMed ID: 2125235
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and morphological changes in myocardium during coronary occlusion and reperfusion in canine hearts: effects of propranolol on myocardial damage.
Ogawa T; Sugiyama S; Hieda N; Ito T; Satake T; Ozawa T
Cardiovasc Res; 1989 May; 23(5):417-23. PubMed ID: 2611809
[TBL] [Abstract][Full Text] [Related]
14. Effects of propranolol on regional O2 supply and O2 consumption in reperfused dog myocardium.
Joselevitz-Goldman J; Upsher ME; Weiss HR
J Pharmacol Exp Ther; 1987 Jul; 242(1):102-7. PubMed ID: 3612518
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin I2 analogue and propranolol prevent ischaemia induced mitochondrial dysfunction through the stabilisation of lysosomal membranes.
Hieda N; Toki Y; Sugiyama S; Ito T; Satake T; Ozawa T
Cardiovasc Res; 1988 Mar; 22(3):219-25. PubMed ID: 3048692
[TBL] [Abstract][Full Text] [Related]
16. Effect of the alpha 1-blocker bunazosin on reperfusion-induced mitochondrial dysfunction in canine hearts.
Hanaki Y; Saito H; Sugiyama S; Ozawa T
Arzneimittelforschung; 1988 Jan; 38(1):11-3. PubMed ID: 2896507
[TBL] [Abstract][Full Text] [Related]
17. Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm.
Takeuchi H; Tanabe M; Okamoto H; Yamazaki M
Neurol Res; 1999 Jul; 21(5):513-6. PubMed ID: 10439434
[TBL] [Abstract][Full Text] [Related]
18. The anti-thromboxane A2 synthetase activity of myocardial tissue and its variation during ischemia and reperfusion in isolated rabbit heart.
Chahine R; Lasserre B; Assaad S
Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):101-6. PubMed ID: 10328329
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of selective inhibitor of thromboxane synthetase (OKY-046) and thromboxane antagonist (ONO-3708) on ischemia-induced mitochondrial dysfunction in canine heart.
Ito T; Ito Y; Torii T; Hieda N; Toki Y; Miyazaki Y; Hashimoto H; Ogawa K; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():392-6. PubMed ID: 2959085
[No Abstract] [Full Text] [Related]
20. Cardioprotective effects of various class I antiarrhythmic drugs in canine hearts.
Hanaki Y; Sugiyama S; Hieda N; Taki K; Hayashi H; Ozawa T
J Am Coll Cardiol; 1989 Jul; 14(1):219-24. PubMed ID: 2738264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
